Metraipolis › archive › dc_432fe2a697f5

Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review — Europe PMC PMID:40940942

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940942
DOI
10.3390/cancers17172845
License (as archived)
solo-consultazione
Archived
2026-11-10T06:23:41.923Z
SHA-256 of the archived text
1b8af78e9354b8b16a9bb5034ea3c446ed5980117f1fce5229551069f4cb75ad
Stable URL of this page
https://metraipolis.com/documento/dc_432fe2a697f5

How to cite

Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review — Europe PMC PMID:40940942 — Europe PMC (en), https://europepmc.org/article/MED/40940942 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_432fe2a697f5 (Metraipolis archive dc_432fe2a697f5, sha256 1b8af78e9354b8b16a9bb5034ea3c446ed5980117f1fce5229551069f4cb75ad)
BibTeX
@misc{dc432fe2a697f5,
  title = {Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review — Europe PMC PMID:40940942},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940942},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_432fe2a697f5; sha256 1b8af78e9354b8b16a9bb5034ea3c446ed5980117f1fce5229551069f4cb75ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940942. Agents can read the archived copy with the MCP tool read_document.